MX9801129A - Agentes farmaceuticos. - Google Patents

Agentes farmaceuticos.

Info

Publication number
MX9801129A
MX9801129A MX9801129A MX9801129A MX9801129A MX 9801129 A MX9801129 A MX 9801129A MX 9801129 A MX9801129 A MX 9801129A MX 9801129 A MX9801129 A MX 9801129A MX 9801129 A MX9801129 A MX 9801129A
Authority
MX
Mexico
Prior art keywords
hydrogen
pharmaceutical agents
formula
inhibitin
cycloalky
Prior art date
Application number
MX9801129A
Other languages
English (en)
Inventor
Mitchell Irvin Steinberg
Fatima Emitel Yakubu-Madus
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX9801129A publication Critical patent/MX9801129A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invencion proporciona un procedimiento para inhibir el deterioro del metabolismo de la glucosa en un mamífero administrado una aminopirimidina sustituida que tiene la formula (Ver Formula) en laque R1, R2 y R3 son, independientemente, hidrogeno, halogeno, alcoxi C1-C4, (alquilo C1-C4)tio, alquilo C1-C4 o cicloalquilo C1-C3; R4 es hidrogeno, formilo, acetilo, propionilo o butirilo, a condicion de que R1,R4 no sean todos hidrogeno al mismo tiempo; o una sal o solvato farmacéuticamente aceptable del mismo.
MX9801129A 1997-02-11 1998-02-10 Agentes farmaceuticos. MX9801129A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79866197A 1997-02-11 1997-02-11

Publications (1)

Publication Number Publication Date
MX9801129A true MX9801129A (es) 1998-11-29

Family

ID=25173964

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9801129A MX9801129A (es) 1997-02-11 1998-02-10 Agentes farmaceuticos.

Country Status (12)

Country Link
EP (1) EP0857483A1 (es)
JP (1) JPH10218773A (es)
KR (1) KR19980071226A (es)
AU (1) AU5387898A (es)
CA (1) CA2229123A1 (es)
CZ (1) CZ39398A3 (es)
HU (1) HUP9800291A2 (es)
IL (1) IL123232A0 (es)
MX (1) MX9801129A (es)
NO (1) NO980546L (es)
SG (1) SG76535A1 (es)
ZA (1) ZA981029B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2727400A (en) * 1999-01-29 2000-08-18 Eli Lilly And Company Moxonidine salts
ITTV20010002U1 (it) 2001-01-12 2002-07-12 Vetraria Biancadese Sas Soc Tavolo avente almeno una prolunga estraibile mediante semplice rotazione
GEP20084540B (en) 2003-01-14 2008-11-25 Arena Pharm Inc 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
CN1751038A (zh) * 2003-02-24 2006-03-22 艾尼纳制药公司 作为葡萄糖代谢调节剂的经取代芳基和杂芳基衍生物及葡萄糖代谢失调的预防和治疗
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
KR101137084B1 (ko) * 2003-10-10 2012-04-24 애보트 프러덕츠 게엠베하 셀렉티브 ⅰ１ 이미다졸린 수용체 작용제 및 엔지오텐신 ⅱ수용체 차단제를 포함하는 약학적 조성물
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
AU2007213887A1 (en) * 2006-01-27 2007-08-16 F. Hoffmann-La Roche Ag Use of 2-imidazoles for the treatment of CNS disorders
KR101176699B1 (ko) 2006-10-19 2012-08-23 에프. 호프만-라 로슈 아게 아미노메틸-4-이미다졸
ATE533755T1 (de) 2006-11-02 2011-12-15 Hoffmann La Roche Substituierte 2-imidazole als modulatoren der mit spurenaminen assoziierten rezeptoren
RU2456281C2 (ru) 2006-11-16 2012-07-20 Ф. Хоффманн-Ля Рош Аг Замещенные 4-имидазолы, способ их получения и их применение
BRPI0720047A2 (pt) 2006-12-13 2013-12-24 Hoffmann La Roche 2-imidazóis como ligantes para receptores associados a aminas de traço (taar)
US20080146523A1 (en) 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
CA2675221C (en) 2007-02-02 2016-02-23 F. Hoffmann-La Roche Ag Novel 2-aminooxazolines as taar1 ligands
KR101222412B1 (ko) 2007-02-15 2013-01-15 에프. 호프만-라 로슈 아게 Ｔａａｒ1 리간드로서의 2-아미노옥사졸린
WO2009003868A2 (en) 2007-07-02 2009-01-08 F. Hoffmann-La Roche Ag 2 -imidazolines having a good affinity to the trace amine associated receptors (taars)
CA2691704A1 (en) 2007-07-03 2009-01-08 F. Hoffmann-La Roche Ag 4-imidazolines and their use as antidepressants
BRPI0813837A2 (pt) 2007-07-27 2015-01-06 Hoffmann La Roche 2-azetidinametanoaminas e 2-pirrolidinametanoaminas como ligantes de taar
JP5341084B2 (ja) 2007-08-03 2013-11-13 エフ．ホフマン−ラ ロシュ アーゲー Ｔａａｒ１リガンドとしてのピリジンカルボキシアミド及びベンズアミド誘導体
US8242153B2 (en) 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
US8354441B2 (en) 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
CA2812061A1 (en) 2010-09-22 2012-03-29 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
EP2829540A1 (en) 2013-07-26 2015-01-28 Abbott Healthcare Products B.V. Synthesis of substituted aminopyridines
AU2016205361C1 (en) 2015-01-06 2021-04-08 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
KR102603199B1 (ko) 2015-06-22 2023-11-16 아레나 파마슈티칼스, 인크. Ｓ1ｐ1 수용체-관련 장애에서의 사용을 위한 (ｒ)-2-(7-(4-시클로펜틸-3-(트리플루오로메틸)벤질옥시)-1,2,3,4-테트라히드로시클로-펜타[ｂ]인돌-3-일)아세트산 (화합물 1)의 결정성 ｌ-아르기닌 염
AU2017234042B2 (en) 2016-03-17 2020-11-19 F. Hoffmann-La Roche Ag 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of TAAR

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323570A (en) * 1978-11-15 1982-04-06 Beiersdorf Aktiengesellschaft Substituted aminopyrimidines
DE4423177A1 (de) * 1994-07-01 1996-01-04 Kali Chemie Pharma Gmbh Antihyperglykämisch wirksame Arzneimittel

Also Published As

Publication number Publication date
CZ39398A3 (cs) 1998-08-12
IL123232A0 (en) 1999-11-30
JPH10218773A (ja) 1998-08-18
KR19980071226A (ko) 1998-10-26
ZA981029B (en) 1999-08-10
HUP9800291A2 (hu) 2001-02-28
CA2229123A1 (en) 1998-08-11
NO980546D0 (no) 1998-02-09
AU5387898A (en) 1998-08-13
HU9800291D0 (en) 1998-04-28
EP0857483A1 (en) 1998-08-12
NO980546L (no) 1998-08-12
SG76535A1 (en) 2000-11-21

Similar Documents

Publication Publication Date Title
MX9801129A (es) Agentes farmaceuticos.
KR960701055A (ko) 인터로이킨-1 및 종양 괴사 인자 억제 활성을 지닌 피라졸로트리아진 (pyrazol itriazines with interleukin-1 and tumour necrosis factor in-hibitory actvity)
IL133623A0 (en) Antithrombotic agents
IL133627A0 (en) Antithrombotic agents
AU4950993A (en) Combination of germicidal agents
CA2396738A1 (en) Thiazole derivatives as active superoxide radical inhibitors
CA2107014A1 (en) Therapeutic Agent for Parkinson's Disease
IL142649A0 (en) Azole derivatives
HK1019878A1 (en) Total synthesis of antitumor acylfulvenes.
EP1140900A4 (en) PYRAZOLE COMPOUNDS AND USE OF SUCH COMPOUNDS
TW360652B (en) Acryloyl substituted disstamycin derivatives, process for preparing them, and pharmaceutical composition comprising them
UA35550C2 (uk) Похідні урацилу, що проявляють гербіцидну активність
MX9702203A (es) Derivados de pirazolil-pirazol substituidos, procedimientos para su preparacion y su uso como agentes con accion herbicida.
BG103735A (en) Method for the preparation of substituted thiazolidindions
MY117086A (en) 3''-aziridino-anthracycline derivatives.
TW350838B (en) Quinoline derivatives
TW350757B (en) Benzisoxazole derivatives and pesticidal compositions containing them
TW259787B (es)
ATE282608T1 (de) Chinoxalindionen
AP9901637A0 (en) Crystalline hydrated sodium salt of (E)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidin-3-ylidene methyl)-1H-indole-2-carboxylic acid.
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use
TW358809B (en) Phenylamidinothiophene compound and anti-inflammatory agent containing the same
TW329388B (en) Intraocular irrigating solution
CA2232267A1 (en) Novel imidazole lipoxygenase inhibitors
ZA9810361B (en) Heterocyclic compounds having MMP and TNF inhibitory activity.